secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOGEN INC. (BIIB)
CIK:        0000875045
Form:       8-K
Filed at:   2025-01-15T23:59:59+00:00
Accession:  0001193125-25-006578
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Biogen appoints Sean Godbout as Chief Accounting Officer effective March 1, 2025
--------------------------------------------------------------------------------

- Sean Godbout to succeed Robin Kramer as CAO and principal accounting officer; Kramer transitions to CFO role upon McDonnell's retirement.
- Michael McDonnell to retire as CFO on March 1, 2025; Kramer previously announced as successor.
- Godbout, age 50, internal promotion from Global Corporate Controller (since Oct 2023), joined Biogen in 2007.
- Base salary $400,000; annual bonus target 40% of base; eligible for long-term incentive grants and executive severance plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875045/000119312525006578/0001193125-25-006578-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875045/000119312525006578/d830064d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-006578

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer